HuGE Literature Finder
Records 1 - 2
| DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma.
Seminars in hematology 2021 1 58 (1): 45-55.
Khouri Jack, Faiman Beth M, Grabowski Dale, Mahfouz Reda Z, Khan Shahper N, Wei Wei, Valent Jason, Dean Robert, Samaras Christy, Jha Babal K, Lazarus Hillard, Campagnaro Erica L, Malek Ehsan, Reed Janice, Karam Mary Ann, Hamilton Kimberly, Fada Sherry, Kalaycio Matt, Liu Hien, Sobecks Ronald, Saunthararajah Yogen, Chew Yap, Orloff Mohammed, Reu Frederic
| The influence of cytidine deaminase -33delC polymorphism on treatment outcome with high-dose cytarabine in Chinese patients with relapsed acute myeloid leukaemia.
Journal of clinical pharmacy and therapeutics 2015 Jul .
He H, Liu Z Q, Li X, Yin J Y, Zhai M, Zhou H
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 20, 2023
- Content source: